FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:705-707 February 28, 2002 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: I am surprised that the target systolic blood pressures in three studies of the renoprotective effects of angiotensin-receptor blockers in patients with type 2 diabetes (Sept. 20 issue)^1,2,3 exceeded the threshold of less than 130 mm Hg recommended in the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI).⁴ After treatment, the mean systolic blood pressure for all treatment groups in each study was 140 mm Hg or higher. What kind of example is this for practicing physicians who treat hypertensive patients with diabetes?

If one strictly adheres . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Chiarelli, F., Di Marzio, D., Santilli, F., Mohn, A., Blasetti, A., Cipollone, F., Mezzetti, A., Verrotti, A. (2005). Effects of Irbesartan on Intracellular Antioxidant Enzyme Expression and Activity in Adolescents and Young Adults With Early Diabetic Angiopathy. Diabetes Care 28: 1690-1697 [Abstract] [Full Text]  
• Ceriello, A., Assaloni, R., Da Ros, R., Maier, A., Piconi, L., Quagliaro, L., Esposito, K., Giugliano, D. (2005). Effect of Atorvastatin and Irbesartan, Alone and in Combination, on Postprandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetic Patients. Circulation 111: 2518-2524 [Abstract] [Full Text]  
• Ceriello, A., Motz, E. (2004). Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited. Arterioscler. Thromb. Vasc. Bio. 24: 816-823 [Abstract] [Full Text]  
• Alter, D. A., Khaykin, Y., Austin, P. C., Tu, J. V., Hux, J. E. (2003). Processes and Outcomes of Care for Diabetic Acute Myocardial Infarction Patients in Ontario: Do physicians undertreat?. Diabetes Care 26: 1427-1434 [Abstract] [Full Text]  
• Ceriello, A. (2003). New Insights on Oxidative Stress and Diabetic Complications May Lead to a "Causal" Antioxidant Therapy. Diabetes Care 26: 1589-1596 [Abstract] [Full Text]